Edit search
Pharmacogenetic determinants for discontinuation of non-ergo…
Pharmacogenetic determinants for discontinuation of non-ergoline dopamine agonists in Parkinson%27s disease.
Pharmacogenetic determinants for discontinuation of non-ergoline dopamine agonists in Parkinson%27s disease.
Article, Chapter
Authors: M.E. Arbouw
Publication: Movement Disorders, Volume:24, Issue:S1, Page(s):s124
Published: Wiley, 2009
ISSN: 0885-3185
  Full text availability for this item
Browse related articles
  Print copies at your library
  Request a copy of this item
Cite this item